Emcure Pharmaceuticals (NSE:EMCURE) Other Net Income (Loss) : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Other Net Income (Loss)?

Emcure Pharmaceuticals's Other Net Income (Loss) for the three months ended in Dec. 2024 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Emcure Pharmaceuticals's quarterly Other Net Income (Loss) increased from Mar. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil) but then declined from Sep. 2024 (₹0 Mil) to Dec. 2024 (₹0 Mil).

Emcure Pharmaceuticals's annual Other Net Income (Loss) declined from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then stayed the same from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹0 Mil).

Emcure Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Emcure Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Other Net Income (Loss) Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

-1,886.58

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial			-	-	-	-	-

Emcure Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Emcure Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines